Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.

Koethe JR, Westfall AO, Luhanga DK, Clark GM, Goldman JD, Mulenga PL, Cantrell RA, Chi BH, Zulu I, Saag MS, Stringer JS.

PLoS One. 2010 Mar 12;5(3):e9680. doi: 10.1371/journal.pone.0009680. Erratum in: PLoS One. 2010; 5(3) doi: 10.1371/annotation/dbc3ee9b-dab4-494b-87d1-7c32b8d684b5.

2.

Kericho CLinic-based ART Diagnostic Evaluation (CLADE): design, accrual, and baseline characteristics of a randomized controlled trial conducted in predominately rural, district-level, HIV clinics of Kenya.

Sawe FK, Obiero E, Yegon P, Langat RC, Aoko A, Tarus J, Kiptoo I, Langat RK, Maswai J, Bii M, Khamadi S, Shikuku KP, Close N, Sinei S, Shaffer DN.

PLoS One. 2015 Feb 23;10(2):e0116299. doi: 10.1371/journal.pone.0116299.

3.

Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.

Jourdain G, Le Cœur S, Ngo-Giang-Huong N, Traisathit P, Cressey TR, Fregonese F, Leurent B, Collins IJ, Techapornroong M, Banchongkit S, Buranabanjasatean S, Halue G, Nilmanat A, Luekamlung N, Klinbuayaem V, Chutanunta A, Kantipong P, Bowonwatanuwong C, Lertkoonalak R, Leenasirimakul P, Tansuphasawasdikul S, Sang-A-Gad P, Pathipvanich P, Thongbuaban S, Wittayapraparat P, Eiamsirikit N, Buranawanitchakorn Y, Yutthakasemsunt N, Winiyakul N, Decker L, Barbier S, Koetsawang S, Sirirungsi W, McIntosh K, Thanprasertsuk S, Lallemant M; PHPT-3 study team..

PLoS Med. 2013 Aug;10(8):e1001494. doi: 10.1371/journal.pmed.1001494.

4.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
5.

Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.

Koller M, Fatti G, Chi BH, Keiser O, Hoffmann CJ, Wood R, Prozesky H, Stinson K, Giddy J, Mutevedzi P, Fox MP, Law M, Boulle A, Egger M.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):e110-9. doi: 10.1097/QAI.0000000000000748.

PMID:
26470034
6.

Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.

Wouters E, Van Damme W, Van Loon F, van Rensburg D, Meulemans H.

Soc Sci Med. 2009 Oct;69(8):1177-85. doi: 10.1016/j.socscimed.2009.07.034.

PMID:
19692165
7.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].

Panel de expertos de GESIDA.; Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2007 Jan;25(1):32-53. Spanish.

PMID:
17261244
8.

Results of a community-based antiretroviral treatment program for HIV-1 infection in Western Uganda.

Kipp W, Konde-Lule J, Saunders LD, Alibhai A, Houston S, Rubaale T, Senthilselvan A, Okech-Ojony J, Kiweewa F.

Curr HIV Res. 2010 Mar;8(2):179-85.

PMID:
20163349
9.

World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.

Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D.

Antivir Ther. 2008;13 Suppl 2:15-23.

PMID:
18575188
10.

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.

Bisson GP, Gross R, Strom JB, Rollins C, Bellamy S, Weinstein R, Friedman H, Dickinson D, Frank I, Strom BL, Gaolathe T, Ndwapi N.

AIDS. 2006 Aug 1;20(12):1613-9. Erratum in: AIDS. 2006 Aug 22;20(13):1790.

PMID:
16868442
11.

Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China.

Wang X, Yang L, Li H, Zuo L, Liang S, Liu W, Dong Y, Yang S, Shang H, Li J, Kang L, Zhong P, Zheng W, Liao L, Xing H, Chen RY, Ruan Y, Shao Y.

Curr HIV Res. 2011 Mar;9(2):103-11.

PMID:
21361864
12.

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006148. Review.

PMID:
16856117
13.

Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions.

Yehia BR, Long JA, Stearns CR, French B, Tebas P, Frank I.

AIDS Care. 2012;24(6):769-77. doi: 10.1080/09540121.2011.630368.

PMID:
22106980
14.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
15.

Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.

Boyer S, March L, Kouanfack C, Laborde-Balen G, Marino P, Aghokeng AF, Mpoudi-Ngole E, Koulla-Shiro S, Delaporte E, Carrieri MP, Spire B, Laurent C, Moatti JP; Stratall ANRS 12110/ESTHER Study Group..

Lancet Infect Dis. 2013 Jul;13(7):577-86. doi: 10.1016/S1473-3099(13)70073-2.

PMID:
23602084
16.

How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa?

Scott Braithwaite R, Nucifora KA, Toohey C, Kessler J, Uhler LM, Mentor SM, Keebler D, Hallett T.

AIDS. 2014 Jan;28 Suppl 1:S73-83. doi: 10.1097/QAD.0000000000000110.

17.

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.

Aghokeng AF, Kouanfack C, Eymard-Duvernay S, Butel C, Edoul GE, Laurent C, Koulla-Shiro S, Delaporte E, Mpoudi-Ngole E, Peeters M.

J Int AIDS Soc. 2013 Jan 31;16:18004. doi: 10.7448/IAS.16.1.18004.

18.

The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy.

Pence BW, Ostermann J, Kumar V, Whetten K, Thielman N, Mugavero MJ.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):194-201.

PMID:
17971712
20.

Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay.

Sivapalasingam S, Wangechi B, Marshed F, Laverty M, Essajee S, Holzman RS, Valentine F.

PLoS One. 2009 Aug 28;4(8):e6828. doi: 10.1371/journal.pone.0006828.

Supplemental Content

Support Center